Investigational Site Number 840001

Denver, Colorado 80262

0 studies enrolling now · 2 studies all time

What they study most

Diffuse Large B-cell Lymphoma, Type 1 Diabetes Mellitus

Studies at this site

• SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients — Completed
• Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin Infusion — Completed